Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Maisel

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
The American Journal of Emergency Medicine|November 17, 2016
Necessity of hospitalization and stress testing in low risk chest pain patientsNeil Beri, Nicholas A Marston, Lori B Daniels, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Journal of the American College of Cardiology|May 7, 2013
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction)Alan Maisel, Christian Mueller, Sean-Xavier Neath, et al.
Circulation|August 22, 2020
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial InfarctionYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Coronary Artery Disease|July 26, 2022
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndromeYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Contributions to Nephrology|May 22, 2013
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)Peter A McCullough, Josee Bouchard, Sushrut S Waikar, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
European Journal of Heart Failure|February 4, 2012
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Sean-Xavier Neath, Judd Landsberg, et al.
Journal of the American College of Cardiology|May 8, 2010
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialAlan Maisel, Christian Mueller, Richard Nowak, et al.
The American Journal of Emergency Medicine|November 17, 2016
Necessity of hospitalization and stress testing in low risk chest pain patientsNeil Beri, Nicholas A Marston, Lori B Daniels, et al.
Circulation. Heart Failure|July 19, 2011
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) studyAlan Maisel, Yang Xue, Kevin Shah, et al.
Journal of the American College of Cardiology|May 7, 2013
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction)Alan Maisel, Christian Mueller, Sean-Xavier Neath, et al.
Circulation|August 22, 2020
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial InfarctionYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Coronary Artery Disease|July 26, 2022
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndromeYu Horiuchi, Nicholas Wettersten, Mitul P Patel, et al.
Contributions to Nephrology|May 22, 2013
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)Peter A McCullough, Josee Bouchard, Sushrut S Waikar, et al.
Pageof 15